Robert Hamilton: The Reality of Stroke Care and Why 81.6% Should be a Wake-Up call
Robert Hamilton, Chief Executive Officer of NeuraSignal, shared on LinkedIn:
”The Reality of Stroke Care: Why 81.6% Should be a Wake-Up call
Even after years of looking at stroke care from both an academic and professional lens, these numbers are eye-opening.
We often talk about how Endovascular Thrombectomy (EVT) and Intravenous Thrombolysis (IVT) have ‘changed the world.’ And they have.
They are nothing short of miraculous for the patients who receive them, especially, EVT with a NNT of 2. But this data is a sobering reminder of the work that remains.
The Challenge ahead
While we rightfully celebrate the breakthroughs that have redefined the field, we cannot ignore the 81.6% of patients who are left with medical management alone.
- We stand on the shoulders of giants: The pioneers of EVT and IVT paved the way.
- The mission is far from complete: Access, timing, and technology must evolve to reach the silent majority.
- Innovation is a responsibility: We have a collective duty to ensure ‘world-class care’ isn’t a privilege for the few, but a standard for all.
What’s Next?
I’m more motivated than ever to push the boundaries of what’s possible.
I’ll be at LSI next week and am looking forward to discussing how we are tackling these gaps at NeuraSignal.
If you’re attending, let’s connect. It’s time to discuss what’s next for the field.”

Stay updated with Hemostasis Today.
-
Mar 13, 2026, 21:19New Canadian Insights on Switching to Longer-Acting Therapy for Hemophilia A – WFH
-
Mar 13, 2026, 21:01Leonardo Roever: Brain Age as a Biomarker of Neuroplasticity and Motor Recovery After Stroke
-
Mar 13, 2026, 20:50William Tembo: Understanding Stroke Through Landmark Clinical Trials
-
Mar 13, 2026, 20:35Jessica Garcia: New Evidence on Thrombin Generation Patterns in Children with Hemophilia A
-
Mar 13, 2026, 20:11Christoph B. Olivier: New Research from Marius Wessinger on Predicting Therapy Success After Pulmonary Embolism
-
Mar 13, 2026, 19:53Wolfgang Miesbach Announces the New English Edition of “Gene Therapy Concepts in the Treatment of Haemophilia”
-
Mar 13, 2026, 17:21Emmanuel J Favaloro: Acquired Hemostasis Disorders Featured in New Issue of Seminars in Thrombosis and Hemostasis
-
Mar 13, 2026, 17:17Paolo Zamboni: New Insights from Australia on Jugular and Azygous Vein Chronic Obstruction
-
Mar 13, 2026, 17:06Srishti Goyal: Can Thalassemia Major Be Prevented?